Radical Prostatectomy Without Prior Biopsy in Selected Patients Evaluated by 18 F-Labeled Prostate-Specific Membrane Antigen–Ligand Positron Emission Tomography/Computed Tomography and Multiparameter Magnetic Resonance Imaging: A Single-Center, Prospective, Single-Arm Trial

Biopsy-free prostatectomy is safe and feasible for patients with evaluation strictly by mpMRI combined with ¹⁸F-PSMA PET/CT.